Status:
COMPLETED
Online Network Intervention to Increase HIV Pre-exposure Prophylaxis Intention
Lead Sponsor:
University of California, Davis
Conditions:
Behavior, Health
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
HIV pre-exposure prophylaxis (or PrEP) is an effective additional preventative measure for reducing the risk of HIV transmission. To address low levels of uptake, there is a need for public health int...
Detailed Description
Roughly 1.7 million people worldwide are infected with HIV each year (UNAIDS, 2017). HIV pre-exposure prophylaxis (or PrEP) refers to taking a daily oral medicine to reduce the risk of contracting HIV...
Eligibility Criteria
Inclusion
- Gay or bisexual male
- Aged 18 and 35
- HIV-negative
- Not on PrEP
- Using an Android smartphone
Exclusion
- Already participating in another HIV-related study.
- Not able or willing to carry an Android smartphone.
Key Trial Info
Start Date :
July 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04771312
Start Date
July 19 2021
End Date
September 15 2021
Last Update
October 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis
Davis, California, United States, 95616